Keywords: Kidney, Diffusion/other diffusion imaging techniques
Purpose To explore whether IVIM-DWI and BOLD-MRI can assess the renal function, Oxford classification and prognostic risk stratification of IgAN patients.
Methods This retrospective study included 46 IgAN patients and 20 healthy volunteers for renal MRI examinations. T2* values on BOLD images and ADC, Dt, Dp, fp values on IVIM-DWI images were measured.
Results: Cortical Dt generated the largest area under the curve for differentiating 5-year risk scores ≤ 10% from 5-year risk scores > 10%, and for differentiating T0 from T1/T2.
Conclusions IVIM-DWI and BOLD-MRI can assess the renal function, Oxford classification, and prognostic risk stratification of IgAN patients.
1. Reich, H.N., et al., Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol, 2007. 18(12): p. 3177-83.
2. Lai, K.N., et al., IgA nephropathy. Nat Rev Dis Primers, 2016. 2: p. 16001.
3. Cattran, D.C., et al., The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int, 2009. 76(5): p. 534-45.
4. Roberts, I.S., et al., The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int, 2009. 76(5): p. 546-56.
5. Trimarchi, H., et al., Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int, 2017. 91(5): p. 1014-1021.
6. Barbour, S.J., et al., Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. JAMA Intern Med, 2019. 179(7): p. 942-952.
7. Liu, Y., et al., Diffusional kurtosis imaging in assessing renal function and pathology of IgA nephropathy: a preliminary clinical study. Clin Radiol, 2018. 73(9): p. 818-826.
8. Mao, W., et al., Chronic kidney disease: Pathological and functional evaluation with intravoxel incoherent motion diffusion-weighted imaging. J Magn Reson Imaging, 2018. 47(5): p. 1251-1259.
9. Khatir, D.S., et al., Reproducibility of MRI renal artery blood flow and BOLD measurements in patients with chronic kidney disease and healthy controls. J Magn Reson Imaging, 2014. 40(5): p. 1091-8.
10. Finsterbusch, J., Improving the performance of diffusion-weighted inner field-of-view echo-planar imaging based on 2D-selective radiofrequency excitations by tilting the excitation plane. J Magn Reson Imaging, 2012. 35(4): p. 984-92.
11. Prasad, P.V., et al., Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney Disease. Am J Nephrol, 2019. 49(2): p. 114-124.
12. Fine, L.G., C. Orphanides, and J.T. Norman, Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl, 1998. 65: p. S74-8.
13. Mariani, G., et al., Renal outcome in IgA nephropathy according to Oxford classification and ultrastructural analysis in a Brazilian center . Clin Nephrol, 2018. 89(4): p. 270-276.
14. Coppo, R., et al., Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int, 2014. 86(4): p. 828-36.
15. Espinosa, M., et al., Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol, 2014. 9(5): p. 897-904.
16. Le, W., et al., Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol, 2012. 13: p. 158.
17. Kang, S.H., et al., The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant, 2012. 27(1): p. 252-8.
18. Soares, M.F.S. and I.S.D. Roberts, Histologic Classification of IgA Nephropathy: Past, Present, and Future. Semin Nephrol, 2018. 38(5): p. 477-484.